4
Changes in Ownership
Protagonist Therapeutics, Inc Filed Acc 0001209191-19-045196
Chief Scientific Officer sold 3,395 shares at $8.85 ($30,044)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Liu David Y Chief Scientific Officer | 2019-08-06 | Sale | −3,395 | $8.85 | $30,044 | 49,802 | D: show line 1 in the form |
| Open-market sales · 3,395 sh · avg $8.85 · $30,044 | |||||||
Loading xslF345X03/doc4.xml…